Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Uterine microcirculation pathways refer to the intricate network of small blood vessels within the uterus—arterioles, capillaries, and venules—and the cellular and molecular systems regulating their function. These pathways are crucial for delivering oxygen and nutrients, removing waste, and enabling key processes such as cyclic tissue remodeling, embryo implantation, and maintenance of pregnancy. Vascular remodeling in the uterus, particularly around implantation and during pregnancy, involves coordinated dilation and reorganization of vessels including spiral arterioles—regulated by endothelial cells, vascular smooth muscle cells, and pericytes—under the influence of signals such as nitric oxide, prostaglandins, and endothelins. Dysregulation leads to disease states like dysmenorrhea, infertility, endometriosis, and preeclampsia, with contributing mechanisms such as impaired vasodilation, excessive vasoconstriction, or abnormal angiogenesis
Modulation of vascular tone: Vasodilatory or vasoconstrictive action on uterine microvessels Alteration of endothelial signaling (nitric oxide, prostaglandins, endothelins) Regulation of vascular permeability and microvascular remodeling
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Uterine microcirculation pathways (null).